Jingwei B. Chen
Randwick, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Correction: Targeted Therapy of TERT-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 11, 2026
PDGFRA in paediatric high-grade glioma - target or distraction?
Journal: Neoplasia (New York, N.Y.)
Published: July 23, 2025
The Super Enhancer-Driven Long Noncoding RNA PRKCQ-AS1 Promotes Neuroblastoma Tumorigenesis by Interacting With MSI2 Protein and Is Targetable by Small Molecule Compounds.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 08, 2024
Targeted Therapy of TERT-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 03, 2020
NEAT1 polyA-modulating antisense oligonucleotides reveal opposing functions for both long non-coding RNA isoforms in neuroblastoma.
Journal: Cellular and molecular life sciences : CMLS
Published: May 01, 2020
The RNA-helicase DDX21 upregulates CEP55 expression and promotes neuroblastoma.
Journal: Molecular oncology
Published: April 21, 2020
Combination therapy with the CDK7 inhibitor and the tyrosine kinase inhibitor exerts synergistic anticancer effects against MYCN-amplified neuroblastoma.
Journal: International journal of cancer
Published: May 07, 2019
Direct effects of Bmi1 on p53 protein stability inactivates oncoprotein stress responses in embryonal cancer precursor cells at tumor initiation.
Journal: Oncogene
Published: February 13, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026